US · Healthcare

Nika BioTechnology Inc (NIKA)

Drug Manufacturers - Specialty & Generic

Nika BioTechnology Inc (NIKA) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for NIKA

P/E ratio

18.00

Nika BioTechnology Inc (NIKA) — FAQ

What is NIKA's P/E ratio?

The price-to-earnings (P/E) ratio for Nika BioTechnology Inc (NIKA) is 18.00 (data as of 2026-05-23).

Does Nika BioTechnology Inc pay a dividend?

Dividend yield is not available in the current snapshot for Nika BioTechnology Inc (NIKA). Check the MyAverix Finance app for the latest dividend data.

What sector is Nika BioTechnology Inc in?

Nika BioTechnology Inc (NIKA) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is NIKA listed on?

NIKA is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)